Condition
Mineralocorticoid Excess
Total Trials
5
Recruiting
1
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Active Not Recruiting3
Recruiting1
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04840342Phase 4Active Not Recruiting
MR Antagonist and LSD1
NCT04439708Active Not Recruiting
Biomarkers and Choroidal Neovascularization
NCT05925569Not ApplicableActive Not Recruiting
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT06495983RecruitingPrimary
Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
NCT04428827Unknown
Outcome of Patients With Primary Aldosteronism
Showing all 5 trials